Search Menu
People

Professor Lesley Anderson

Professor Lesley Anderson
Professor Lesley Anderson
Professor Lesley Anderson

PhD MPHe BSc(Hons) PGCHET FHEA

Director - Interdisciplinary Centre for Health, Wellbeing & Nutrition

Accepting PhDs

About
Email Address
lesley.anderson@abdn.ac.uk
Office Address
B1006 Crombie Annexe
Old Aberdeen Campus
College Bounds
AB24 3TS

View on Map

School/Department
Senior Vice Principals
ResearchGate
Pure
Twitter
Linkedin
ORCiD
Scopus

Biography

I am the University's Interdisciplinary Director for Health, Nutrition and Wellbeing and a Personal Chair in Health Data Science. 

I trained at Queen's University Belfast (QUB) graduating with a PhD in cancer epidemiology in 2004 and an undergraduate degree (first class Honours) in Biomedical Science in 2001. I have a Masters in Population Health-based Evidence obtained by distance learning from the University of Manchester (distinction level) in 2006. I joined QUB as an academic in 2010 after completing two highly respected fellowships: an Academic Fellowship (funded by the UK Medical Research Council) and a Cancer Prevention Fellowship at the National Cancer Institute, National Institute of Health, Maryland, United States of America. I joined the Northern Ireland Cancer Registry (NICR) part-time in 2017 as Deputy Director overseeing the production of Official Statistics for Northern Ireland and developing the NICR Research Advisory Group.

I have over 24 years experience in research utilising healthcare data from across the globe. I have established international partnerships within the USA, Europe, Australia, Africa and Asia to facilitate research in the fields of health data science and public health with a focus on cancer research. Global Health Research Partnerships with researchers in Angola, Mongolia and Vietnam are seeking to identify ways to improve public knowledge and reduce the burden of cancer. 

I was Grampian Academic Lead for the Industrial Centre for Artificial Intelligence in Digital Diagnostics (iCAIRD), a £25 million programme of research bringing together 40 academic, NHS and industrial partners. My current research is focusing on artificial intelligence evaluation and working with advanced health data science approaches to improve health care.

Qualifications

  • PhD Public Health 
    2004 - Queen's University Belfast 
    Title. The aetiology of Barrett's oesophagus and oesophageal adenocarcinoma: results from an all-Ireland case-control study.
  • MPHe Population Health 
    2006 - University of Manchester 
  • BSc (Hons) Biomedical Science 
    2001 - Queen's University Belfast 
  • PGCHET Postgraduate Certificate in Higher Education Teaching 
    2009 - Queen's University Belfast 

Memberships and Affiliations

Internal Memberships
  • University Management Group (UMG), University of Aberdeen, 2024-date.
  • Senate Academicus, University of Aberdeen (Oct 2022-Sept 2026).
  • Aberdeen Centre for Health Data Science Senior Leadership Team (Sept 2020-date)
External Memberships
  • North of Scotland AI Strategy Regional Implementation Oversight Group (Apr 2024-date).
  • External Programme and Module Examiner, Masters in Public Health, University of Manchester, 2019-2023.
  • Cancer Research UK Prevention and Population Research Committee, Expert Review Panel (2022-date).
  • Blood Cancer UK - Data themed Funding Committee (2022-date).
  • Breast Cancer Now Tissue Bank Advisory Council (2021-date).
  • National Cancer Research Institute Haematological Oncology Group member (2019-date)

 

Latest Publications

View My Publications

Prizes and Awards

  • Abstract Award ‘Identifying the optimal AI workflow integration for breast screening’, EUSOBI 2024.
  • Data Driven Innovation Award– iCAIRD, Digital Health and Care Awards, 2024.
  • Positive Research Culture Award, Excellence Awards 2023, University of Aberdeen, 2023.
  • Data Driven Innovation – iCAIRD for the implementation of our imaging research platforms (SHAIP and Pathology Living Lab). Holyrood Digital Health and Care Awards, 2023.
  • iCAIRD won the Multiparty Collaboration Award at the Scottish Knowledge Exchange Awards in 2022.
  • Innovative Collaboration Award: iCAIRD, Scotland’s Life Sciences Awards 2021.
  • Outstanding Research Team – iCAIRD, Excellence Awards 2022, University of Aberdeen, 2022.
  • Outstanding Research Project – Covid-19 Response & Recovery Award 2021, Excellence Awards 2021, University of Aberdeen, 20 21.
  • STAR (STAff Recognition Scheme) for exceptional performance and contribution in your role. QUB, 2020.
  • STAR (STAff Recognition Scheme) for exceptional performance and contribution in your role. QUB, 2019.
  • Best Clinical Poster Prize, Haematology Association Ireland Annual Conference, October 2016.
  • Presentation award. School of Medicine, Dentistry and Biomedical Sciences Postdoc Society Symposium, February 2010.
  • Poster prize, Nursing and Allied Health Professional section, Cancer Recognised Research Group Retreat, September 2008.
  • Dr J.D. Williamson Prize for best postgraduate medical research, Faculty of Medicine and Health Science, Queen’s University Belfast, 2007.
  • Poster of Distinction. Digestive Disease Week, 2007.
  • Highly commended for the BUPA Foundation Epidemiology Award, October 2005.
  • Awarded best presentation at the Ulster Society of Gastroenterology meeting, October 2005.
  • Travel scholarship for International Society of Gastrointestinal Oncology meeting, 2005.
  • Digestive Disease Week Conference, May 2005. Platform presentation in the Distinguished Abstract Plenary Session.  The abstract was noted as newsworthy.
  • All Ireland Cancer Conference, 2003. Best poster prize.
  • Awarded best presentation at the Ulster society of Gastroenterology meeting, March 2002
  • Foundation Award, Queen’s University Belfast, 2001.
Research

Research Overview

 

Health Data Research

Professor Anderson has over 19 years experience of using health data to research cancer and chronic disease epidemiology. Her research interests are aligned around the following research themes:

  • Rare cancers 
  • Infection-related cancers
  • Pre-cancerous conditions
  • Chronic diseases

 

Research Areas

Accepting PhDs

I am currently accepting PhDs in Applied Health Sciences, Biomedical Sciences, Artificial Intelligence.

Please get in touch if you would like to discuss your research ideas further.

Email Me

Applied Health Sciences

Supervising
Accepting PhDs
View Research Area

Biomedical Sciences

Supervising
Accepting PhDs
View Research Area

Artificial Intelligence

Supervising
Accepting PhDs
View Research Area

Research Specialisms

  • Healthcare Science
  • Biomedical Sciences
  • Health Informatics
  • Environmental and Public Health
  • Oncology

Our research specialisms are based on the Higher Education Classification of Subjects (HECoS) which is HESA open data, published under the Creative Commons Attribution 4.0 International licence.

Current Research

Artificial Intelligence (AI) Evaluation

Projects looking to evaluate AI tools for translation into healthcare. 

Funding from Friends of ANCHOR for a large comprehensive mammography database - ‘ANCHOR breast imaging dataset’ has been secured expanding potential to undertake AI evaluations in breast screening. 

Cancer Prevention Research

Professor Anderson is leading the world's first nationwide case-control study of myeloproliferative neoplasms, the MOSAICC (MyelOproliferative neoplasmS: An In-depth Case-Control) study.  The study is recruiting patients from across the United Kingdom and Ireland collecting information on potential risk factors (causes) and assessing the quality of life of these patients. 

 

Past Research

MOSAICC pilot study - largest study of myeloproliferative neoplasms to date. Study designed to determine best methodological approach for a UK-wide study which is ongoing looking at the aetiology and impact of a MPN diagnosis. 

FINBAR study - large all-Ireland case-control study of oesophageal cancer and precancerous conditions. This study has led to many publications looking at the aetiology of these oesophageal conditions and is part of an international collaboration - the BEACON consortium. 

EUROCARE - I have worked with the EUROCARE consortium to undertake a range of studies looking at variations in the survival of oesophgeal, gastric, small intestine and head and neck cancer and haematological malignancies.

RARECARE - I have worked with European colleagues to look at thyroid cancers and the burden and centralised treatment in Europe of rare tumours.

HPV and Head and Neck cancer - study identified that p16 is an insufficient marker for stage classification of oropharyngeal cancer. The data from this study is being combined with wider cohorts to evaluate this further and to look at restaging of oropharyngeal cancer. 

COELIAC DISEASE - A study that I led looking at gluten sensitivity and coeliac disease and outcomes (cancer and all-cause mortality) led to the identification of adverse outcomes for those with gluten sensitivity but without a confirmed coeliac diagnosis. 

MOSAICC Study

There is little information about what causes myeloproliferative neoplasms (MPNs). Patients often ask, “why do I have this disease?”, and for the majority there is no obvious reason. The MOSAICC study (MyelOproliferative neoplasmS: An In-depth Case-Control) is a UK-wide study that aims to identify what causes myeloproliferative neoplasms (MPNs). The MOSAICC study is open in 19 sites across the UK and in Cork Ireland. 

MPN Voice

Collaborations

Professor Anderson is a member of the BEACON consortium (https://esocan.org/beacon/). 

Professor Anderson has research collaborations with researchers in the UK, Ireland, USA, across Europe, Australia, Angola, Vietnam and Mongolia. 

Supervision

My current supervision areas are: Applied Health Sciences, Biomedical Sciences, Artificial Intelligence.

PhD

  • 2nd supervisor: “Enhancing long-term evaluation and monitoring of responsible AI deployments in medical context.” University of Aberdeen, 2024-2028. Funded: University of Aberdeen
  • 1st supervisor: ‘What modifications could be made to the UK breast screening service with Artificial Intelligence (AI) approaches to improve service delivery and participant outcome?’ University of Aberdeen, 2024-2028. Funded: Self-funded
  • 2nd supervisor (MD): ‘AI supported image analysis in large bowel camera capsule endoscopy (AICE).’ University of Aberdeen, 2023-2027. Funded: University of Aberdeen.
  • 2nd supervisor: ‘Methods for the economic evaluation of artificial intelligence algorithms in breast cancer diagnosis.’ University of Aberdeen, 2023-2027. Funded: University of Aberdeen.
  • 1st PhD supervisor: ‘Investigating the routes to diagnosis of Myeloproliferative Neoplasms using multidisciplinary approaches.’ University of Aberdeen, 2021-2025. Funded: University of Aberdeen.
  • 1st PhD supervisor: ‘ARCHERY PROJECT: AI TO REVOLUTIONISE THE PATIENT CARE PATHWAY IN HIP AND KNEE ARTHROPLASTY’. University of Aberdeen, 2021-2024. Funded: Chief Scientist Office.
  • 2nd PhD supervisor: ‘Investigating the significance of haematological malignancy precursors with a particular focus on multiple myeloma’, QUB 2019-2020. Funded: Dfe. Changed to 3rd supervisor when I changed job.
  • 1st PhD supervisor: ‘Implementation of electronic cigarette policy in Kuwait.’ QUB 2016-2021. Funded: Kuwaiti government. Changed to 3rd supervisor when I changed job.
  • 1st PhD supervisor: ‘Barriers to cervical cancer screening and diagnosis in Northern Ireland.’ QUB 2018-2021. Funded: Saudi/ Kuwaiti government. Changed to 3rd supervisor when I changed job.
  • 1st PhD supervisor: ‘Assessing the impact of hydroxyurea treatment for children with sickle cell anaemia in Cabinda province, Angola.’ QUB 2016-2020. Funded: Angolan government.
  • 1st PhD supervisor: ‘Assessing the impact of MGUS’, QUB 2015-date. Funded: DEL.
  • 1st PhD supervisor: 'An exploratory case-control study of myeloproliferative neoplasms', QUB 2012-2015. Funded: MPN Voice.
  • 1st PhD supervisor: 'Prior medical history, drug exposure and risk of multiple myeloma', QUB 2011-2013. Funded: DEL.
  • 3rd PhD supervisor: ‘Investigating the association between aspirin & non-steroidal anti-inflammatory drugs and head and neck cancer & malignant melanoma’, QUB 2009-2011. Funded: DEL.

Masters

  • 1st supervisor, MSc in Public Health: ‘Assessing breast density in women attending for breast screening’, University of Aberdeen, 2024.
  • 1st supervisor, MSc in Public Health: ‘Assessing knowledge and attitudes to artificial intelligence use in medical x-rays’, University of Aberdeen, 2022.
  • 1st supervisor, MSc in Public Health: ‘Analysing the impact of social factors and distance to care on breast cancer outcomes in Scotland’, University of Aberdeen, 2021.
  • 1st supervisor, MSc in Health Data Science: ‘Are Gluten-Free Foods Unhealthy?’, University of Aberdeen, 2021.
  • 1st supervisor, MSc in Public Health: ‘Assessing the impact of COVID-19 on the quality of life of patients with a Myeloproliferative Neoplasm’, QUB 2020.
  • 1st supervisor, MSc in Bioinformatics and computational genomics: ‘Natural Language Processing Tool for Breast Cancer Registration’, QUB 2020.
  • 1st supervisor, MSc in Public Health: ‘Systematic review of arts-based approaches to increase awareness of breast cancer’, QUB 2019.
  • 1st supervisor, MSc in Public Health: ‘Knowledge and attitudes of HPV in Angola’, QUB 2018.
  • 1st supervisor, MSc in Public Health: ‘Attitudes and knowledge of parents to HPV vaccination – a quantitative investigation’, QUB 2016.
  • 1st supervisor, MSc in Public Health: ‘Assessing the impact of MGUS’, QUB 2015.
  • 1st supervisor, MSc in Public Health: ‘Anti-diabetic medications & risk of MGUS/myeloma’, QUB 2014.
  • 1st supervisor, MSc in Public Health: ‘Investigating birth factors and Hodgkin lymphoma’, QUB 2010.
  • 1st supervisor, MSc in Public Health.: ‘Investigating incidence trends of Human papillomavirus related and unrelated head and neck cancers’, QUB 2010.
  • 1st supervisor, MPH: 'Determination of the predictors of Acute Human Immunodeficiency Virus type 1 and 2 for the targeted screening using p24 Enzyme Linked Immunosorbent Assay: a retrospective study from populations in Kenya, South Africa and Uganda' University of Liverpool, 2010.

Undergraduate

  • 1st supervisor, Public Health ‘Attitudes and behaviours regarding tanning in Northern Ireland: A mixed-methods study of Queen’s University of Belfast students.’ UoA 2021-2022.
  • 1st supervisor, Human Biology ‘Attitudes and behaviours regarding tanning in Northern Ireland: A mixed-methods study of Queen’s University of Belfast students.’ QUB 2017-2018.
  • 1st supervisor, Human Biology ‘Coeliac Disease – Diagnosis, Trends, Cancer Risk and Mortality’ QUB 2017-2018.
  • 2nd supervisor, Human Biology ‘Gluten Free’ Food for Thought.’ QUB 2018-2019.
  • 1st supervisor, Human Biology ‘Occupational risk factors for myeloproliferative neoplasms.’ QUB 2017-2018.
  • 1st supervisor, Human Biology ‘Incidence of Paediatric Cancer in Africa: a systematic review.’ QUB 2017-2018.
  • 2nd supervisor, Human Biology ‘Knowledge, Attitudes & Practice of Paediatric Cancer in Africa: a systematic review’ QUB 2017-2018.
  • 1st supervisor, Human Biology ‘Parental knowledge & attitudes to HPV vaccination.’ QUB 2016-2017.
  • 1st supervisor, Human Biology ‘Oral dysplasia transformation rate’. QUB 2015/16.
  • 1st supervisor, Human Biology ‘Incidence, prevalence and survival of MGUS’ QUB 2015-2016.
  • 1st supervisor, Biomedical Science ‘Human Papilloma virus in head and neck cancers’, 2012-2013.
  • 1st supervisor, Biomedical Science ‘Langerhans’ cells and immune response biomarkers in head and neck cancers’, 2012-2013.
  • 1st supervisor, BSc Anatomy ‘Investigating psychological risk factors for oesophageal adenocarcinoma’, QUB 2010-2011.
  • 1st supervisor, BSc Anatomy ‘Investigating survival differences between HPV-related and unrelated head and neck cancers’, QUB 2010-2011.

Funding and Grants

Current Research

  • Anderson (PI), De Vries, Lip, Staff. ANCHOR Breast imaging dataset. Friends of Anchor, 2024 £69,408.96.
  • Anderson (PI), De Vries, D’Ambruoso, Adamczyk, Lip, Arumapperuma, Camanda. Implementing Artificial Intelligence-enabled thermal imaging and ultrasound to detect breast cancer in low and middle income settings. International Science Partnerships Fund (ISPF) ODA Project Grants £19,981.78.
  • Anderson (PI), McShane, McMullin, McKnight. MPN Discovery - assessing gene-environment interaction. Blood Cancer UK. 2023-2026. £277,666.11.
  • Anderson (PI), Toenail trace elements for assessing risk of myeloproliferative neoplasms. Friends of Anchor, 2023-2024. £11,193.
  • Anderson (PI), Abutheraa N, Iversen L, Robertson C, Tarburn E. Investigating the incidence, prevalence and outcomes of myeloproliferative neoplasms to aid service planning and delivery in NHS Grampian. NHS Endowments, 2023-2024. £18,837.
  • Anderson (PI), Lip (CI), Staff, De Vries. Grampian's Evaluation of Mia an Innovative National Breast Screening Initiative. Kheiron Medical Technologies Limited under NIHR Phase 4 AI Award. 2022-2024, £413,689.
  • Omar, Anderson (Co-I), MacLennan, MacLennan, Speirs & European Association of Urology Guidelines Office. Optimal treatment for patients with solid tumours in Europe through artificial intelligence.. European Commission, 2021-2026, €10,459,997.00 (£565,400 to UoA). Part of the 21.3 million Euro project. https://www.optima-oncology.eu/
  • Farrow, Anderson (Co-I) & Ashcroft. ARCHERY PROJECT: AI TO REVOLUTIONISE THE PATIENT CARE PATHWAY IN HIP AND KNEE ARTHROPLASTY. Chief Scientist Office, Scotland, 2021-2024, £237,568.
  • MOSAICC study : Anderson (PI). MOSAICC (MyelOproliferative neoplasmS: An In-depth Case-Control) study in Aberdeen. Friends of Anchor, 2021-2023. £22,064; Anderson (PI), McShane, Mc Mullin, Duncombe, Fritschi, DeVocht, Mesa. MOSAICC study. MPN Voice. 2021-2023. £75,631; McShane, Anderson (Co-I), McMullin. MOSAICC study. Leukaemia and Lymphoma NI, £47,000. 2021-2022; Anderson (PI). MOSAICC Ireland, Mercy Hospital Foundation. 2023-2024, £49177.89.
  • McShane, Gavin, Anderson (Co-I). Investigating the impact of geographic inequalities and local service provision on multiple myeloma patient outcomes within the UK. Myeloma UK, 2021-2023. £100,000.

Prior Research (last 5 years)

  • Elsberger, Anderson (Co-I), Scottish National Audit of Breast Cancer in Older Patients (S_NABCOP). NHSG Endownment Breast Cancer Research Fund 2022-2023, £13,422.
  • Abderson (PI), Abutheraa N. Using Occupational Integrated Database Exposure Assessment (OccIDEAS) to assess occupational exposure risk for MyeloProliferative Neoplasms (MPN) patients and their control: A comparison study. University of Aberdeen Internal Funding to Pump-Prime Research and Research Networks. 2023. £9,931.75.
  • Harrison, Blackwood, Anderson (Co-I). The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics https://icaird.com/. Extension bid (2022-2023). Innovate UK. £1,611,191. Total iCAIRD project grant £9,970,020 (UoA total: £394,477).
  • Anderson (PI), D’Ambruoso, Camanda, Buco, Chocolate, Lohfeld. Evaluating opportunities and barriers to establishing an autonomous and functional sickle cell anaemia (SCA) unit in Cabinda, Angola. Scottish Funding Council, 2020-2021, £45,563.
  • Murchie, Anderson (Co-I), Analysing NCDA data to support the adoption of Early Cancer Diagnostic Centres in Scotland. Chief Scientist Office, Scotland, 2021. £50,000.
  • Black, Anderson (Co-I), Fluck, Hollick, Nath, Sawhney. MINIMISING IMPACT ON VULNERABLE PATIENTS: DATA DRIVEN DESIGN, MONITORING AND ADAPTATION OF COVID AND NON-COVID CLINICAL CARE PATHWAYS. Chief Scientist Office, Scotland. 2020. £61,452.
  • McShane, Kunzmann, Anderson (Co-I), Lohfeld, Donnelly, Bayarmongol, Jigjidsuren, Enkhjargal, Tudev, Badamsuren, Jugder. Reducing cancer burden in Mongolia: Co-developing an Evidence-based Plan to Strengthen the Health Care System and Inform Policy. NIHR, £93,487.
  • Gavin, Anderson (Co-I). Northern Ireland Colorectal cancer Audit, Public Health Agency NI, £81,531.
  • Gavin, Anderson (Co-I). Northern Ireland Cancer Registry, Public Health Agency NI, £823,560.
  • Gavin, Anderson (Co-I). Northern Ireland Cardiovascular Registry. Heart Research UK, 2019-2021. £149,991.
  • Lohfeld, Anderson (Co-I), Santin, Donnelly, Franziska, Jenkins, Burgess, Nguyen, Murphy, Hang, Truong, Schroeder, Hang. Documenting how the arts and storytelling can save lives: The Viet Nam Breast Cancer project, MRC-AHRC. 2018-2020. £165,416.
  • Lohfeld, Anderson (Co-I), Promoting Sustainable Health and Wellbeing in Angola. 2018-2019, Department for the Economy Northern Ireland, £52,793.

 

Teaching

Teaching Responsibilities

 

PhD Opportunities

Supervising students with an interest in Health Data Science and cancer research.  Please contact lesley.anderson@abdn.ac.uk 

Publications

Page 1 of 2 Results 1 to 100 of 197

  • Liquid biopsy to identify Barrett’s oesophagus, dysplasia and oesophageal adenocarcinoma: the EMERALD multicentre study

    Miyoshi, J., Mannucci, A., Scarpa, M., Gao, F., Toden, S., Whitsett, T., Inge, L. j., Bremner, R. m., Takayama, T., Cheng, Y., Bottiglieri, T., Nagetaal, I. d., Shrubsole, M. j., Zaidi, A. h., Wang, X., Coleman, H. g., Anderson, L. a., Meltzer, S. j., Goel, A., FINBAR-EMERALD
    Gut
    Contributions to Journals: Articles

  • The Clinical Practice Integration of Artificial Intelligence (CPI-AI) framework: a proposed application of IDEAL principles to artificial intelligence applications in trauma and orthopaedics

    Farrow, L., Meek, D., Leontidis, G., Campbell, M., Harrison, E. M., Anderson, L.
    Bone & Joint Research, vol. 13, no. 9, pp. 507-512
    Contributions to Journals: Articles

  • TNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinoma

    von Buchwald, C., Jakobsen, K. K., Carlander, A. F., Tous, S., Grønhøj, C., Rasmussen, J. H., Brooks, J., Taberna, M., Mena, M., Morey, F., Bruni, L., Batis, N., Brakenhoff, R. H., René Leemans, C., Jong, R. J. d., Klussmann, J. P., Wuerdemann, N., Wagner, S., Dalianis, T., Marklund, L., Mirghani, H., Schache, A., James, J. A., Huang, S. H., O’Sullivan, B., Nankivell, P., Broglie, M. A., Hoffmann, M., Quabius, E. S., Anderson, L. A., Craig, S. G., Alemany, L., Mehanna, H.
    European Journal of Cancer, vol. 211, 114329
    Contributions to Journals: Articles

  • Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021

    Barclay, N. L., Burn, E., Delmestri, A., Duarte-Salles, T., Golozar, A., Man, W. Y., Tan, E. H., Tietzova, I., OPTIMA Consortium, Prieto-Alhambra, D., Newby, D., Anderson, L., MacLennan, S., MacLennan, S., Speirs, V., Zibaite, S., Boyle, M., Murray, C., McDonald, D.
    Scientific Reports, vol. 14, 19069
    Contributions to Journals: Articles

  • Pathways to MPN presentation and time-to-diagnosis: results from a cross-sectional study

    Tarburn, E., Iversen, L., Robertson, C., McShane, C., Duncombe, A., McMullin, M., Harrison, C., Mesa, R., Anderson, L. A.
    BJGP Open
    Contributions to Journals: Articles

  • Autoimmune Conditions and Gastric Cancer Risk in a Population-based Study in the United Kingdom

    Murphy, J. D., Gadalla, S. M., Anderson, L., Rabkin, C. S., Cardwell, C. R., Song, M., Camargo, M. C.
    British Journal of Cancer, vol. 131, pp. 138-148
    Contributions to Journals: Articles

  • Pathways to MPN Presentation and Diagnosis: Results from a Cross-Sectional Study

    Tarburn, E., Iversen, L., Robertson, C., McShane, C., Duncombe, A. S., McMullin, M. F., Harrison, C., Mesa, R., Anderson, L.
    BJGP Open
    Contributions to Journals: Articles

  • A stakeholder analysis to prepare for real-world evaluation of integrating artificial intelligent algorithms into breast screening (PREP-AIR study): a qualitative study using the WHO guide

    Newlands, R., Bruhn, H., Rzewuska Diaz, M., Lip, G., Anderson, L., Ramsay, C.
    BMC Health Services Research, vol. 24, no. 1, 569
    Contributions to Journals: Articles

  • Service and clinical impacts of reader bias in breast cancer screening: a retrospective study

    de Vries, C. F., Staff, R. T., Dymiter, J. A., Boyle, M., Anderson, L. A., Lip, G., iCAIRD Radiology Collaboration
    British Journal of Radiology, vol. 97, no. 1153, pp. 120-125
    Contributions to Journals: Articles

  • Revisiting Cancer Diagnosis in Scotland: Further Insights from the Second Scottish National Cancer Diagnosis Audit

    Maxwell, S., Kynn, M., Weller, D., Anderson, L., Murchie, P., Kalhori, M. R. (ed.)
    European Journal of Cancer Care, vol. 2024, 1117968
    Contributions to Journals: Articles

  • The aetiology and burden of myeloproliferative neoplasms in the United Kingdom: the MyelOproliferative neoplasmS: an In-depth case-control (MOSAICC) study protocol.

    Abutheraa, N., Tarburn, E., McShane, C., Duncombe, A. S., McMullin, M. F., Anderson, L.
    BMC Cancer, vol. 23, 1207
    Contributions to Journals: Articles

  • The JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden

    Orbell, L. Y., Abutheraa, N., Duncombe, A. S., McMullin, M. F., Mesa, R., McShane, C., James, G., Anderson, L.
    European Journal of Haematology, vol. 4, no. 4, pp. 1071-1080
    Contributions to Journals: Articles

  • The Impact of Rurality on Patient Experience and Diagnostic Pathway Intervals in Scotland’s Cancer Patients: Further Results from a National Cancer Diagnosis Audit Cancer Epidemiology

    Maxwell, S., Pearce, C., Kynn, M., Anderson, L. A., Weller, D., Murchie, P.
    Cancer Epidemiology, vol. 86, 102414
    Contributions to Journals: Articles

  • Impact of Different Mammography Systems on Artificial Intelligence Performance in Breast Cancer Screening

    de Vries, C., Colosimo, S., Staff, R., Dymiter, J., Yearsley, J., Dinneen, D., Boyle, M., Harrison, D., Anderson, L., Lip, G.
    Radiology: Artificial Intelligence, vol. 5, no. 3, e220146
    Contributions to Journals: Articles

  • AI in breast screening mammography: breast screening readers' perspectives

    de Vries, C. F., Colosimo, S. J., Boyle, M., Lip, G., Anderson, L. A., Staff, R. T., iCAIRD Radiology Collaboration
    Insights into Imaging, vol. 13, no. 1, 186
    Contributions to Journals: Articles

  • Prioritization of THose aWaiting hip and knee ArthroplastY(PATHWAY): protocol for development of a stakeholder led clinical prioritization tool

    Farrow, L., Clement, N. D., Smith, D., Meek, D. R. M., Ryan, M., Gillies, K., Anderson, L., Ashcroft, G. P.
    Bone & Joint Open, vol. 3, no. 10, pp. 753-758
    Contributions to Journals: Articles

  • eQTL set-based association analysis identifies novel susceptibility loci for Barrett's esophagus and esophageal adenocarcinoma

    Wang, X., Gharahkhani, P., Levine, D. M., Fitzgerald, R. C., Gockel, I., Corley, D. A., Risch, H. A., Bernstein, L., Chow, W., Onstad, L., Shaheen, N. J., Lagergren, J., Hardie, L. J., Wu, A. H., Pharoah, P. D. P., Liu, G., Anderson, L. A., Iyer, P. G., Gammon, M. D., Caldas, C., Ye, W., Barr, H., Moayyedi, P., Harrison, R., Watson, R. P., Attwood, S., Chegwidden, L., Love, S. B., MacDonald, D., deCaestecker, J., Prenen, H., Ott, K., Moebus, S., Venerito, M., Lang, H., Mayershofer, R., Knapp, M., Veits, L., Gerges, C., Weissmüller, J., Reeh, M., Nöthen, M. M., Izbicki, J. R., Manner, H., Neuhaus, H., Rösch, T., Böhmer, A. C., Hölscher, A. H., Anders, M., Pech, O., Schumacher, B., Schmidt, C., Schmidt, T., Noder, T., Lorenz, D., Vieth, M., May, A., Hess, T., Kreuser, N., Becker, J., Ell, C., Tomlinson, I., Palles, C., Jankowski, J. A., Whiteman, D. C., MacGregor, S., Schumacher, J., Vaughan, T. L., Buas, M. F., Dai, J. Y.
    Cancer Epidemiology, Biomarkers and Prevention, vol. 31, no. 9, cebp.0096
    Contributions to Journals: Articles

  • Supporting someone with cancer during the COVID-19 pandemic: A mixed methods analysis of cancer carer's health, Quality of Life and need for support

    Santin, O., Mc Mullan, J., Jenkins, C., Anderson, L. A., Mc Shane, C. M.
    Health & Social Care in the Community, vol. 30, no. 5, pp. e3246-e3252
    Contributions to Journals: Articles

  • Evaluation of Human Papillomavirus (HPV) Knowledge among Healthcare Professionals: A study of conference attendees in Angola

    Ikiroma, A., Santin, O., Camanda, J., Chocolate, F., Pelinganga, O., Jordao, H., Tommasino, M., Lohfeld, L., Anderson, L.
    Global Public Health
    Contributions to Journals: Articles

  • Using Artificial Intelligence to Revolutionise the Patient Care Pathway in Hip and Knee Arthroplasty (ARCHERY): Protocol for the Development of a Clinical Prediction Model

    Farrow, L., Ashcroft, G. P., Zhong, M., Anderson, L.
    JMIR Research Protocols, vol. 11, no. 5, e37092
    Contributions to Journals: Articles

  • Spatial disparities in the reported incidence and survival of myeloproliferative neoplasms in Australia

    Cameron, J. K., Fritschi, L., Ross, D. M., Anderson, L., Baade, P. D.
    Pathology, vol. 54, no. 3, pp. 328-335
    Contributions to Journals: Articles

  • A National Network of Safe Havens: Scottish Perspective

    Gao, C., McGilchrist, M., Mumtaz, S., Hall, C., Anderson, L. A., Zurowski, J., Gordon, S., Lumsden, J., Munro, V., Wozniak, A., Sibley, M., Banks, C., Duncan, C., Linksted, P., Hume, A., Stables, C. L., Mayor, C., Caldwell, J., Wilde, K., Cole, C., Jefferson, E.
    Journal of Medical Internet Research, vol. 24, no. 3, pp. e31684
    Contributions to Journals: Articles

  • Menopausal hormone therapy and risk of biliary tract cancers

    Jackson, S. S., Pfeiffer, R., Gabbi, C., Anderson, L., Gadalla, S. M., Koshiol, J.
    Hepatology, vol. 75, no. 2, pp. 309-321
    Contributions to Journals: Articles

  • Not all small HER2 positive breast cancers have the same clinical outcome in the North-East of Scotland

    Pawloy, K., Urquhart, G. N., Brown, D., Daltrey, I., Soh, F., Anderson, L., Elsberger, B.
    Cancer Treatment and Research Communications, vol. 31, no. 2022, 100549
    Contributions to Journals: Articles

  • Interpretation and Reporting of Predictive or Diagnostic Machine Learning Research in Trauma & Orthopaedics

    Farrow, L., Zhong, M., Anderson, L., Ashcroft, G., Meek, R. M. D.
    Bone and Joint Journal, vol. 103B, no. 12, pp. 1754-1758
    Contributions to Journals: Articles

  • A systematic review and meta-analysis of cancer risk in myotonic dystrophy: consistent with a general increased risk of cancer

    McConville, K., McShane, C., Fallis, R., McConville, K., Anderson, L.
    Neuromuscular Disorders, vol. 31, no. Supplement 1, S121
    Contributions to Journals: Abstracts

  • The psychosocial impact of the COVID-19 pandemic on MGUS, smouldering and active myeloma patients: findings from an international survey

    Quinn, S., Anderson, L., Lohfeld, L., McShane, C. M.
    British Journal of Haematology, vol. 194, no. 2, pp. 294-297
    Contributions to Journals: Letters

  • Does risk of progression from Barrett’s esophagus to esophageal adenocarcinoma change based on the number of non-dysplastic endoscopies?

    Kunzmann, A. T., Coleman, H. G., Johnston, B. T., Turkington, R. C., McManus, D., Anderson, L., Thrift, A. P.
    Digestive Diseases and Sciences, vol. 66, pp. 1965–1973
    Contributions to Journals: Articles

  • Patient's perspectives of living with a precancerous condition: monoclonal gammopathy of undetermined significance (MGUS)

    Murphy, B., McShane, C. M., Santin, O., Treanor, C., Bryne, B., Donnelly, M., Anderson, L.
    European Journal of Oncology Nursing, vol. 51, 101901
    Contributions to Journals: Articles

  • Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma

    Dighe, S. G., Chen, J., Yan, L., He, Q., Gharahkhani, P., Onstad, L., Levine, D. M., Palles, C., Ye, W., Gammon, M. D., Iyer, P. G., Anderson, L. A., Liu, G., Wu, A. H., Dai, J. Y., Chow, W., Risch, H. A., Lagergren, J., Shaheen, N. J., Bernstein, L., Corley, D. A., Prenen, H., deCaestecker, J., MacDonald, D., Moayyedi, P., Barr, H., Love, S. B., Chegwidden, L., Attwood, S., Watson, P., Harrison, R., Ott, K., Moebus, S., Venerito, M., Lang, H., Mayershofer, R., Knapp, M., Veits, L., Gerges, C., Weismüller, J., Gockel, I., Vashist, Y., Nöthen, M. M., Izbicki, J. R., Manner, H., Neuhaus, H., Rösch, T., Böhmer, A. C., Hölscher, A. H., Anders, M., Pech, O., Schumacher, B., Schmidt, C., Schmidt, T., Noder, T., Lorenz, D., Vieth, M., May, A., Hess, T., Kreuser, N., Becker, J., Ell, C., Ambrosone, C. B., Moysich, K. B., MacGregor, S., Tomlinson, I., Whiteman, D. C., Jankowski, J., Schumacher, J., Vaughan, T. L., Madeleine, M. M., Hardie, L. J., Buas, M. F.
    Carcinogenesis, vol. 42, no. 3, pp. 369-377
    Contributions to Journals: Articles

  • Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients

    Palmer, J., Mead-Harvey, C., Harrison, C., Dueck, A. C., Eckert, R., E Kosiorek, H., Muxi, P., Pemmaraju, N., Arguelles, G. R., Vannucchi, A., Gupta, V., Mascarenhas, J., Taylor, K., Gowin, K. L., Geyer, H. L., Shimoda, K., Kiladjian, J., Komatsu, N., Shan, G. K. L., Abello, V., Gomez-Almaguer, D., Scherber, R., Jiang, Q., Zuo, X., Huberty, J., Anderson, L., Langlais, B. T., Brazeau, A., Woehrle, M., Mauro, M. J., Mesa, R.
    62nd American Society of Hematology Annual Meeting and Exposition
    Contributions to Conferences: Abstracts

  • Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma

    Dong, J., Maj, C., Tsavachidis, S., Ostrom, Q. T., Gharahkhani, P., Anderson, L. A., Wu, A. H., Ye, W., Bernstein, L., Borisov, O., Schröder, J., Chow, W., Gammon, M. D., Liu, G., Caldas, C., Pharoah, P. D., Risch, H. A., May, A., Gerges, C., Anders, M., Venerito, M., Schmidt, T., Izbicki, J. R., Hölscher, A. H., Schumacher, B., Vashist, Y., Neuhaus, H., Rösch, T., Knapp, M., Krawitz, P., Böhmer, A., Iyer, P. G., Reid, B. J., Lagergren, J., Shaheen, N. J., Corley, D. A., Gockel, I., Fitzgerald, R. C., Cook, M. B., Whiteman, D. C., Vaughan, T. L., Schumacher, J., Thrift, A. P., Stomach and Oesophageal Cancer Study (SOCS) Consortium
    Gastroenterology, vol. 159, no. 6, pp. 2065-2076.E1
    Contributions to Journals: Articles

  • Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus

    Xie, S., Fang, R., Huang, M., Dai, J., Thrift, A., Anderson, L., Chow, W., Bernstein, L., Gammon, M. D., Risch, H. A., Shaheen, N. J., Reid, B. J., Wu, A. H., Iyer, P. G., Liu, G., Corley, D. A., Whiteman, D. C., Caldas, C., Pharoah, P. D., Hardie, L. J., Fitzgerald, R. C., Shen, H., Vaughan, T. L., Lagergren, J.
    Clinical Gastroenterology and Hepatology, vol. 18, no. 12, pp. 2701-2709.e3
    Contributions to Journals: Articles

  • Changes in the Demographic and Clinicopathological Characteristics of Thyroid Cancer: A Population-Based Investigation in Algeria, 1993-2013

    Boukheris, H., Bettayeb, A., Anderson, L., Zineb, A., Benbachir, F., Attar, S., Saim, H., Rouigeb, K., Berber, N.
    Journal of Cancer Epidemiology, vol. 2020, 7812791
    Contributions to Journals: Articles

  • Rare thyroid malignancies in Europe: data from the information network on rare cancers in Europe (RARECAREnet)

    Locati, L., Cavalieri, S., Maso, L. D., Busco, S., Anderson, L., Botta, L., Jose Bento, M., Carulla, M., Lopez, M. D. C., Fusco, M., Guevara, M., Innos, K., Johannesen, T. B., Micallef, R., Minicozzi, P., Panato, C., Petrova, D., Rubio-Casadevall, J., Smailyte, G., Vitale, M. F., Trama, A.
    Oral Oncology, vol. 108, 104766
    Contributions to Journals: Articles

  • Aetiology of Myeloproliferative Neoplasms

    McMullin, M. F., Anderson, L.
    Cancers, vol. 12, no. 7, pp. 1-11
    Contributions to Journals: Review articles

  • Cancer incidence projections in Northern Ireland to 2040

    Donnelly, D. W., Anderson, L., Gavin, A., Northern Ireland Cancer Registry Group
    Cancer Epidemiology, Biomarkers and Prevention, vol. 29, no. 7, pp. 1398-1405
    Contributions to Journals: Articles

  • Modifiable lifestyle and medical risk factors associated with myeloproliferative neoplasms

    Duncombe, A. S., Anderson, L., James, G., De Vocht, F., Fritschi, L., Mesa, R., Clarke, M., McMullin, M.
    HemaSphere, vol. 4, no. 1, e327
    Contributions to Journals: Articles

  • Comparison of molecular assays for HPV testing in oropharyngeal squamous cell carcinomas: A population-based study in Northern Ireland

    Craig, S. G., Anderson, L. A., Moran, M., Graham, L., Currie, K., Rooney, K., Robinson, M., Bingham, V., Cuschieri, K. S., McQuaid, S., Schache, A. G., Jones, T. M., McCance, D., Salto-Tellez, M., McDade, S. S., James, J. A.
    Cancer Epidemiology Biomarkers and Prevention, vol. 29, no. 1, pp. 31-38
    Contributions to Journals: Articles

  • Improving identification of cognitive impairment in fragility fracture patients: impact of educational guidelines on current practice

    Kennedy, G., Mohandas, P., Anderson, L., Kennedy, M., Shirley, D.
    Geriatric orthopaedic surgery & rehabilitation, vol. 11, pp. 1-7
    Contributions to Journals: Articles

  • Diabetes in relation to Barrett’s esophagus and adenocarcinomas of the esophagus: a pooled study from the International Barrett’s and Esophageal Adenocarcinoma Consortium

    Petrick, J., Li, N., Anderson, L., Bernstein, L., Corley, D. A., El-Serag, H. B., Hardikar, S., Liao, L., Liu, G., Murray, L., Rubenstein, J. H., Schneider, J. I., Shaheen, N. J., Thrift, A. P., van den Rubenstein, P., Vaughan, T. L., Whiteman, D. C., Wu, A. H., Zhao, W., Gammon, M. D., Cook, M. B.
    Cancer, vol. 125, no. 23, pp. 4210-4223
    Contributions to Journals: Articles

  • Association between aspirin use and biliary tract cancer survival

    Jackson, S. S., Pfeiffer, R. M., Liu, Z., Anderson, L. A., Tsai, H. T., Gadalla, S. M., Koshiol, J.
    JAMA Oncology, vol. 5, no. 12, pp. 1802-1804
    Contributions to Journals: Letters

  • No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study

    Dong, J., Gharahkhani, P., Chow, W. H., Gammon, M. D., Liu, G., Caldas, C., Wu, A. H., Ye, W., Onstad, L., Anderson, L. A., Bernstein, L., Pharoah, P. D., Risch, H. A., Corley, D. A., Fitzgerald, R. C., Iyer, P. G., Reid, B. J., Lagergren, J., Shaheen, N. J., Vaughan, T. L., MacGregor, S., Love, S., Palles, C., Tomlinson, I., Gockel, I., May, A., Gerges, C., Anders, M., Böhmer, A. C., Becker, J., Kreuser, N., Thieme, R., Noder, T., Venerito, M., Veits, L., Schmidt, T., Schmidt, C., Izbicki, J. R., Hölscher, A. H., Lang, H., Lorenz, D., Schumacher, B., Mayershofer, R., Vashist, Y., Ott, K., Vieth, M., Weismüller, J., Nöthen, M. M., Moebus, S., Knapp, M., Stomach and Esophageal Cancer Study Consortium
    Clinical Gastroenterology and Hepatology, vol. 17, no. 11, pp. 2227-2235
    Contributions to Journals: Articles

  • Benign tumors in myotonic dystrophy type I target disease-related cancer sites

    Alsaggaf, R., St. George, D. M. M., Zhan, M., Pfeiffer, R. M., Wang, Y., Anderson, L. A., Liu, Z., Koshiol, J., Bauer, A. J., Wagner, K. R., Greene, M. H., Amr, S., Gadalla, S. M.
    Annals of Clinical and Translational Neurology, vol. 6, no. 8, pp. 1510-1518
    Contributions to Journals: Articles

  • Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink

    Liu, Z., Alsaggaf, R., Mcglynn, K. A., Anderson, L. A., Tsai, H. T., Zhu, B., Zhu, Y., Mbulaiteye, S. M., Gadalla, S. M., Koshiol, J.
    Gut, vol. 68, no. 8, pp. 1458-1464
    Contributions to Journals: Articles

  • Predictors of an early death in patients diagnosed with colon cancer: A retrospective case-control study in the UK

    Donnelly, C., Hart, N., McCrorie, A. D., Donnelly, M., Anderson, L., Ranaghan, L., Gavin, A.
    BMJ Open, vol. 9, no. 6, e026057
    Contributions to Journals: Articles

  • Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach

    Craig, S. G., Anderson, L. A., Schache, A. G., Moran, M., Graham, L., Currie, K., Rooney, K., Robinson, M., Upile, N. S., Brooker, R., Mesri, M., Bingham, V., McQuaid, S., Jones, T., McCance, D. J., Salto-Tellez, M., McDade, S. S., James, J. A.
    British Journal of Cancer, vol. 120, pp. 827-833
    Contributions to Journals: Articles

  • Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014

    Baade, P. D., Ross, D. M., Anderson, L. A., Forsyth, C., Fritschi, L.
    American Journal of Hematology, vol. 94, no. 4, pp. E107-E109
    Contributions to Journals: Letters

  • Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors

    Kunzmann, A. T., Cañadas Garre, M., Thrift, A. P., McMenamin, ?. C., Johnston, B. T., Cardwell, C. R., Anderson, L. A., Spence, A. D., Lagergren, J., Xie, S. H., Smyth, L. J., McKnight, A. J., Coleman, H. G.
    Gastroenterology, vol. 156, no. 1, pp. 43-45
    Contributions to Journals: Articles

  • Communication strategies for rare cancers: A systematic review protocol

    Bell, C., Kerr, K., Moore, K., McShane, C., Anderson, L., McKnight, A. J., McAneney, H.
    Systematic reviews , vol. 8, 102
    Contributions to Journals: Review articles

  • Low knowledge and awareness of monoclonal gammopathy of undetermined significance (MGUS) among general practitioners

    McShane, C. M., Murphy, B., Santin, O., Anderson, L. A.
    BMC Family Practice, vol. 20, 61
    Contributions to Journals: Articles

  • Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus

    Dong, J., Levine, D. M., Buas, M. F., Zhang, R., Onstad, L., Fitzgerald, R. C., Corley, D. A., Shaheen, N. J., Lagergren, J., Hardie, L. J., Reid, B. J., Iyer, P. G., Risch, H. A., Caldas, C., Caldas, I., Pharoah, P. D., Liu, G., Gammon, M. D., Chow, W. H., Bernstein, L., Bird, N. C., Ye, W., Wu, A. H., Anderson, L. A., MacGregor, S., Whiteman, D. C., Vaughan, T. L., Thrift, A. P., Stomach and Oesophageal Cancer Study (SOCS) Consortium
    Clinical Gastroenterology and Hepatology, vol. 16, no. 10, pp. 1598-1606.e4
    Contributions to Journals: Articles

  • Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett’s Esophagus: An Analysis of the Barrett’s and Esophageal Adenocarcinoma Consortium

    Wang, Z., Shaheen, N. J., Whiteman, D. C., Anderson, L. A., Vaughan, T. L., Corley, D. A., El-Serag, H. B., Rubenstein, J. H., Thrift, A. P.
    American journal of gastroenterology, vol. 113, no. 8, pp. 1148-1155
    Contributions to Journals: Articles

  • Model for Identifying Individuals at Risk for Esophageal Adenocarcinoma

    Kunzmann, A. T., Thrift, A. P., Cardwell, C. R., Lagergren, J., Xie, S., Johnston, B. T., Anderson, L. A., Busby, J., McMenamin, ?. C., Spence, A. D., Coleman, H. G.
    Clinical Gastroenterology and Hepatology, vol. 16, no. 8, pp. 1229-1236.e4
    Contributions to Journals: Articles

  • Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink

    Karimi, P., Birmann, B. M., Anderson, L. A., McShane, C. M., Gadalla, S. M., Sampson, J. N., Mbulaiteye, S. M.
    British Journal of Haematology, vol. 181, no. 4, pp. 505-514
    Contributions to Journals: Articles

  • Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants

    Dong, J., Buas, M. F., Gharahkhani, P., Kendall, B. J., Onstad, L., Zhao, S., Anderson, L. A., Wu, A. H., Ye, W., Bird, N. C., Bernstein, L., Chow, W. H., Gammon, M. D., Liu, G., Caldas, C., Pharoah, P. D., Risch, H. A., Iyer, P. G., Reid, B. J., Hardie, L. J., Lagergren, J., Shaheen, N. J., Corley, D. A., Fitzgerald, R. C., Whiteman, D. C., Vaughan, T. L., Thrift, A. P., Stomach and Oesophageal Cancer Study (SOCS) Consortium
    Gastroenterology, vol. 154, no. 5, pp. 1273-1281.e3
    Contributions to Journals: Articles

  • Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink

    Wang, Y., Pfeiffer, R. M., Alsaggaf, R., Meeraus, W., Gage, J. C., Anderson, L. A., Bremer, R. C., Nikolenko, N., Lochmuller, H., Greene, M. H., Gadalla, S. M.
    International Journal of Cancer, vol. 142, no. 6, pp. 1174-1181
    Contributions to Journals: Articles

  • The MOSAICC study: Assessing feasibility for biological sample collection in epidemiology studies and comparison of DNA yields from saliva and whole blood samples

    James, G., McMullin, M. F., Duncombe, A. S., Clarke, M., Anderson, L. A.
    Annals of Human Genetics, vol. 82, no. 2, pp. 114-118
    Contributions to Journals: Articles

  • Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR Study

    Petrick, J. L., Falk, R. T., Hyland, P. L., Caron, P., Pfeiffer, R. M., Wood, S. N., Dawsey, S. M., Abnet, C. C., Taylor, P. R., Guillemette, C., Murray, L. J., Anderson, L. A., Cook, M. B.
    PloS ONE, vol. 13, no. 1, e0190325
    Contributions to Journals: Articles

  • Monoclonal gammopathy of undetermined significance as viewed by haematology healthcare professionals

    McShane, C. M., Murphy, B., Lim, K. H., Anderson, L. A.
    European Journal of Haematology, vol. 100, no. 1, pp. 20-26
    Contributions to Journals: Articles

  • Hormone replacement therapy and risk of multiple myeloma and monoclonal gammopathy of undetermined significance (MGUS) in the UK Clinical Practice Research Datalink

    Bradley, M., McShane, C., Murray, L., Landgren, O., Hughes, C., Anderson, L.
    Contributions to Conferences: Papers

  • Hormonal and reproductive factors and subsequent risk of haematological malignancies: findings from the UK Biobank

    Bhandari, S., McShane, C., Kunzmann, A., McMenamin, U., Anderson, L.
    Contributions to Conferences: Posters

  • INCIDENCE AND PREVALENCE OF SICKLE CELL DISEASE. A SYSTEMATIC REVIEW AND META-ANALYSIS

    Camanda, J., Santin, O., Mills, K., McShane, C., Edge, L., Gyanchandani, A., Vijhayan, S., Anderson, L.
    Haematology Association Ireland Annual Meeting 2017
    Contributions to Conferences: Posters

  • Knowledge and awareness of monoclonal gammopathy of undetermined significance (MGUS) among General Practitioner’s.

    McShane, C., Murphy, B., Anderson, L.
    Haematology Association Ireland Annual Meeting 2017
    Contributions to Conferences: Posters

  • Living with MGUS. How does it compare to the other premalignant conditions?

    Murphy, B., McShane, C., Santin, O., Donnelly, M., Anderson, L.
    Contributions to Conferences: Papers

  • Knowledge or noise? Making sense of General Practitioners’ and Consultant use of two-week-wait referrals for suspected cancer

    Donnelly, C., Hart, N., McCrorie, A. D., Anderson, L., Donnelly, M., Murchie, P., Gavin, A.
    British Journal of Cancer, vol. 117, no. 5, pp. 597-603
    Contributions to Journals: Articles

  • Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

    Gatta, G., Capocaccia, R., Botta, L., Mallone, S., De Angelis, R., Ardanaz, E., Comber, H., Dimitrova, N., Leinonen, M. K., Siesling, S., van der Zwan, J. M., Van Eycken, L., Visser, O., Žakelj, M. P., Anderson, L. A., Bella, F., Kaire, I., Otter, R., Stiller, C. A., Trama, A.
    Lancet Oncology, vol. 18, no. 8, pp. 1022-1039
    Contributions to Journals: Articles

  • The prevalence of viral agents in esophageal adenocarcinoma and Barrett's esophagus: A systematic review

    Kunzmann, A. T., Graham, S., McShane, C. M., Doyle, J., Tommasino, M., Johnston, B., Jamison, J., James, J. A., McManus, D., Anderson, L. A.
    European Journal of Gastroenterology and Hepatology, vol. 29, no. 7, pp. 817-825
    Contributions to Journals: Review articles

  • External Validation of the Michigan Barrett's Esophagus Prediction Tool

    Thrift, A. P., Vaughan, T. L., Anderson, L. A., Whiteman, D. C., El-Serag, H. B.
    Clinical Gastroenterology and Hepatology, vol. 15, no. 7, pp. 1124-1126
    Contributions to Journals: Articles

  • Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: A population-based case-control study

    Shivappa, N., Hebert, J. R., Anderson, L. A., Shrubsole, M. J., Murray, L. J., Getty, L. B., Coleman, H. G.
    British Journal of Nutrition, vol. 117, no. 9, pp. 1323-1331
    Contributions to Journals: Articles

  • Sex steroid hormones in relation to Barrett’s esophagus: An analysis of the FINBAR study

    Cook, M. B., Wood, S., Hyland, P. L., Caron, P., Drahos, J., Falk, R. T., Pfeiffer, R. M., Dawsey, S. M., Abnet, C. C., Taylor, P. R., Guillemette, C., Murray, L. J., Anderson, L. A.
    Andrology, vol. 5, no. 2, pp. 240-247
    Contributions to Journals: Articles

  • Net survival in peripheral T-cell lymphoma in Europe between 2000 and 2007: results from the Rarecarenet database

    Mounier, M., Maynadié, M., botta, L., Pasiarski, M., Macek, P., Anderson, L., Marcos-Gragera, R., Agius, D., Trama, A., Gatta, G.
    Contributions to Conferences: Papers

  • Vulnerability to anti-vaccine campaigns in Ireland..could it be low knowledge?

    Prue, G., McShane, C., Santin, O., Shapiro, G., Ackroyd, S., Haughey, C., Kunzmann, A., Rosberger, Z., Anderson, L.
    Contributions to Conferences: Papers

  • Nonsteroidal anti-inflammatory drug use is not associated with reduced risk of Barrett's Esophagus

    Thrift, A. P., Anderson, L. A., Murray, L. J., Cook, M. B., Shaheen, N. J., Rubenstein, J. H., El-Serag, H. B., Vaughan, T. L., Schneider, J. L., Whiteman, D. C., Corley, D. A.
    American journal of gastroenterology, vol. 111, no. 11, pp. 1528-1535
    Contributions to Journals: Articles

  • HOW COMMON IS MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)? A SYSTEMATIC REVIEW

    McShane, C., Heng Lim, K., Gilkinson, A., Murphy, B., Anderson, L.
    Contributions to Conferences: Papers

  • Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis

    Gharahkhani, P., Fitzgerald, R. C., Vaughan, T. L., Palles, C., Gockel, I., Tomlinson, I., Buas, M. F., May, A., Gerges, C., Anders, M., Becker, J., Kreuser, N., Noder, T., Venerito, M., Veits, L., Schmidt, T., Manner, H., Schmidt, C., Hess, T., Böhmer, A. C., Izbicki, J. R., Hölscher, A. H., Lang, H., Lorenz, D., Schumacher, B., Hackelsberger, A., Mayershofer, R., Pech, O., Vashist, Y., Ott, K., Vieth, M., Weismüller, J., Nöthen, M. M., Attwood, S., Barr, H., Chegwidden, L., de Caestecker, J., Harrison, R., Love, S. B., MacDonald, D., Moayyedi, P., Prenen, H., Watson, R. G., Iyer, P. G., Anderson, L. A., Bernstein, L., Chow, W. H., Hardie, L. J., Lagergren, J., Liu, G.
    The Lancet Oncology, vol. 17, no. 10, pp. 1363-1373
    Contributions to Journals: Articles

  • Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis

    Kendall, B. J., Rubenstein, J. H., Cook, M. B., Vaughan, T. L., Anderson, L. A., Murray, L. J., Shaheen, N. J., Corley, D. A., Chandar, A. K., Li, L., Greer, K. B., Chak, A., El-Serag, H. B., Whiteman, D. C., Thrift, A. P.
    Clinical Gastroenterology and Hepatology, vol. 14, no. 10, pp. 1412-1419.e3
    Contributions to Journals: Articles

  • A Systematic Review On Monoclonal Gammopathy Of Undetermined Significance (MGUS) Survival

    McShane, C., Anderson, L.
    Contributions to Conferences: Papers

  • ESTABLISHING A POPULATION-BASED REGISTER OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE IN NORTHERN IRELAND

    McShane, C., Murray, L., Gavin, A., Roman, E., Wang, H., Anderson, L.
    Contributions to Conferences: Papers

  • LIFESTYLE AND MEDICAL RISK FACTORS ASSOCIATED WITH MYELOPROLIFERATIVE NEOPLASMS: RESULTS FROM THE PILOT MOSAICC STUDY

    Anderson, L., James, G., Duncombe, A. S., deVocht, F., Fritschi, L., Mesa, R., Clarke, M., McMullin, M.
    Contributions to Conferences: Papers

  • Minor allele frequency of myeloproliferative neoplasm mutations in the Irish blood donor population

    Titmarsh, G. J., McKay, G. J., Lawler, M., Anderson, L. A., McMullin, M. F.
    Hematological Oncology, vol. 34, no. 3, pp. 161-164
    Contributions to Journals: Articles

  • Constrained Score Statistics Identify Genetic Variants Interacting with Multiple Risk Factors in Barrett's Esophagus

    Dai, J. Y., Tapsoba, J. d. D., Buas, M. F., BEACON Consortium, Risch, H. A., Vaughan, T. L., Chow, W. H., Shaheen, N. J., Anderson, L., Corley, D. A., Gammon, M. D., Hardie, L. J., Lagergren, J., Whiteman, D. C.
    American Journal of Human Genetics, vol. 99, no. 2, pp. 352-365
    Contributions to Journals: Articles

  • HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland

    Anderson, L. A., O'Rorke, M. A., Wilson, R., Jamison, J., Gavin, A. T., on behalf of the Northern Ireland HPV Working Group
    Journal of Medical Virology, vol. 88, no. 7, pp. 1262-1270
    Contributions to Journals: Articles

  • The prevalence of Infectious agents in oesophageal adenocarcinoma: a systematic review

    Kunzmann, A., Graham, S., McShane, C., Doyle, J., Tomassino, M., Jamison, J., James, J., McManus, D., Gheit, T., Anderson, L.
    Contributions to Conferences: Papers

  • Patient perspectives of a diagnosis of myeloproliferative neoplasm in a case control study

    McMullin, M. F., James, G., Duncombe, A. S., de Vocht, F., Fritschi, L., Clarke, M., Anderson, L. A.
    Experimental Hematology and Oncology, vol. 5, no. 1, 14
    Contributions to Journals: Articles

  • Dietary magnesium, calcium:magnesium ratio and risk of reflux oesophagitis, Barrett’s oesophagus and oesophageal adenocarcinoma: A population-based case-control study

    Dai, Q., Cantwell, M. M., Murray, L. J., Zheng, W., Anderson, L. A., Coleman, H. G., FINBAR Study Group
    British Journal of Nutrition, vol. 115, no. 2, pp. 342-350
    Contributions to Journals: Articles

  • Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium

    Drahos, J., Xiao, Q., Risch, H. A., Freedman, N. D., Abnet, C. C., Anderson, L. A., Bernstein, L., Brown, L., Chow, W., Gammon, M. D., Kamangar, F., Liao, L. M., Murray, L. J., Ward, M. H., Ye, W., Wu, A. H., Vaughan, T. L., Whiteman, D. C., Cook, M. B.
    International Journal of Cancer, vol. 138, no. 1, pp. 55-64
    Contributions to Journals: Articles

  • MYELOPROLIFERATIVE NEOPLASM PATIENT SYMPTOM BURDEN AND QUALITY OF LIFE: EVIDENCE OF SIGNIFICANT IMPAIRMENT COMPARED TO CONTROLS USING MULTIVARIATE ANALYSIS

    Anderson, L., James, G., Dueck, A., Duncombe, A. S., Mesa, R., Scherber, R., E Kosiorek, H., deVocht, F., Clarke, M., McMullin, M.
    Contributions to Conferences: Papers

  • MYELOPROLIFERATIVE NEOPLASM SYMPTOM BURDEN AND QUALITY OF LIFE: RESULTS FROM THE PILOT MOSAICC STUDY

    Anderson, L., James, G., Duncombe, A. S., Mesa, R., Scherber, R., Dueck, A., De Vocht, F., Clarke, M., McMullin, M.
    Contributions to Conferences: Papers

  • Myeloproliferative Neoplasm Patient Symptom Burden and Quality of Life: Evidence of Significant Impairment Compared to Controls Using Multivariate Analysis

    Anderson, L., James, G., Dueck, A., Duncombe, A. S., Mesa, R., Scherber, R., E Kosiorek, H., deVocht, F., Clarke, M., McMullin, M.
    Contributions to Conferences: Papers

  • Myeloproliferative neoplasms: an in-depth case-control study

    McMullin, M., Duncombe, A. S., Titmarsh, G., deVocht, F., Fritschi, L., Mesa, R., Clarke, M., Anderson, L.
    ASH - American Society of Hematology 57th Annual Meeting and Exposition
    Contributions to Conferences: Posters

  • Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study

    Gatta, G., Botta, L., Sánchez, M. J., Anderson, L. A., Pierannunzio, D., Licitra, L., Hackl, M., Zielonke, N., Oberaigner, W., Eycken, E. V., Henau, K., Valerianova, Z., Dimitrova, N., Sekerija, M., Zvolský, M., Dušek, L., Storm, H., Engholm, G., Mägi, M., Aareleid, T., Malila, N., Seppä, K., Velten, M., Troussard, X., Bouvier, V., Launoy, G., Guizard, A. V., Faivre, J., Bouvier, A. M., Arveux, P., Maynadié, M., Woronoff, A. S., Robaszkiewicz, M., Baldi, I., Monnereau, A., Tretarre, B., Bossard, N., Belot, A., Colonna, M., Molinié, F., Bara, S., Schvartz, C., Lapôtre-Ledoux, B., Grosclaude, P., Meyer, M., Stabenow, R., Luttmann, S., Eberle, A., Brenner, H., Nennecke, A.
    European Journal of Cancer, vol. 51, no. 15, pp. 2130-2143
    Contributions to Journals: Articles

  • Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5

    Anderson, L. A., Tavilla, A., Brenner, H., Luttmann, S., Navarro, C., Gavin, A. T., Holleczek, B., Johnston, B. T., Cook, M. B., Bannon, F., Sant, M., Hackl, M., Zielonke, N., Oberaigner, W., Van Eycken, E., Henau, K., Valerianova, Z., Dimitrova, N., Sekerija, M., Zvolský, M., Dusek, L., Storm, H., Engholm, G., Mägi, M., Aareleid, T., Malila, N., Seppä, K., Velten, M., Troussard, X., Bouvier, V., Launoy, G., Guizard, A. V., Faivre, J., Bouvier, A. M., Arveux, P., Maynadié, M., Robaszkiewicz, M., Woronoff, A. S., Baldi, I., Monnereau, A., Tretarre, B., Bossard, N., Belot, A., Colonna, M., Molinié, F., Meyer, M., Sanchez, M. J., Khan, S., Lawrence, G., Wilkinson, J.
    European Journal of Cancer, vol. 51, no. 15, pp. 2144-2157
    Contributions to Journals: Articles

  • Myeloproliferative neoplasm patient symptom burden and quality of life: Evidence of significant impairment compared to controls

    Anderson, L. A., James, G., Duncombe, A. S., Mesa, R., Scherber, R., Dueck, A. C., de Vocht, F., Clarke, M., Mcmullin, M. F.
    American Journal of Hematology, vol. 90, no. 10, pp. 864-870
    Contributions to Journals: Articles

  • Is Europe doing better in cancer care since the 90s? The latest findings from the EUROCARE-5 study

    Sant, M., Francisci, S., Minicozzi, P., Otter, R., Primic-Zakeli, M., Gatta, G., Rossi, S., Baili, P., Anderson, L. A., Holleczek, B., Lepage, C., Crocetti, E., Trama, A., Marcos-Gragera, R., Visser, O., Berrino, F., Capocaccia, R., De Angelis, R.
    18th ECCO - 40th ESMO European Cancer Congress
    Contributions to Conferences: Posters

  • Erratum: How common are myeloproliferative neoplasms? A systematic review and meta-analysis [Am. J. Hematol. 89:581-587, 2014. DOI: 10.1002/ajh.23690]

    Titmarsh, G. J., Duncombe, A. S., McMullin, M. F., O'Rorke, M., Mesa, R., De Vocht, F., Horan, S., Fritschi, L., Clarke, M., Anderson, L. A.
    American Journal of Hematology, vol. 90, no. 9, pp. 850
    Contributions to Journals: Comments and Debates

  • Establishing a population-based register of monoclonal gammopathy of undetermined significance (MGUS) in Northern Ireland

    McShane, C. M., Murray, L. J., Gavin, A. T., Roman, E., Wang, H., Anderson, L. A.
    Contributions to Conferences: Papers

  • Myeloproliferative neoplasm patients experience significant symptom burden.

    James, G., McMullin, M., Duncombe, A. S., Mesa, R., Anderson, L.
    NCIN Cancer Outcomes Conference
    Contributions to Conferences: Posters

  • Features of the diagnostic pathway associated with early death from colon cancer: A nested case-control study in a UK region

    Donnelly, C., Ranaghan, L., Anderson, L. A., Hart, N., Donnelly, M., Gavin, A.
    European Journal of Cancer Care, vol. 24, no. Supplement S1, pp. 5
    Contributions to Journals: Articles

  • Risk of myeloid neoplasms after solid organ transplantation

    Morton, L. M., Gibson, T. M., Clarke, C. A., Lynch, C. F., Anderson, L. A., Pfeiffer, R., Landgren, O., Weisenburger, D. D., Engels, E. A.
    Leukemia, vol. 28, pp. 2317-2323
    Contributions to Journals: Articles
Show 10 | 25 | 50 | 100 results per page

Refine

Books and Reports

Chapters in Books, Reports and Conference Proceedings

Contributions to Conferences

Contributions to Journals

Update